Anti-LXN Antibody

This polyclonal antibody from Antibodies.com targets human Latexin (LXN), a highly conserved cytoplasmic carboxypeptidase inhibitor implicated as a tumor suppressor in melanoma, prostate, and gastric cancers. Raised in rabbit hosts and supplied as an unconjugated 100 µl aliquot, the reagent is validated for Western blot (WB) and immunohistochemistry (IHC) workflows. Researchers investigating apoptosis regulation, stem cell biology, or comparative mammalian carboxypeptidase inhibition profiles can deploy this antibody to probe endogenous LXN expression in human cell lines and tissue sections. The polyclonal format offers broader epitope coverage than monoclonal alternatives, which is useful when studying LXN splice variants or post-translationally modified forms. Storage at -20 °C in working aliquots preserves antibody activity through multiple freeze-thaw cycles, and brief centrifugation before use recovers material that may have aggregated during transit. Each vial is intended for research use only and supports studies exploring Latexin's role as a biomarker of cellular senescence and a negative regulator of tumor progression in human cancer models.